BB Biotech AG

Swiss Stock Exchange:BION.SW

Sector

🏥 Health Care

Industries

🧬 Biotechnology

💰 Hedge Funds

💼 Private Equity

Location

Switzerland

Market Cap

USD 2.15 B

Share Price

USD 39.23

Avg Daily Volume

82,332

Change (1 day)

0.19%

Change (1 year)

-17.11%

Change (YTD)

0.23%

BB Biotech AG Total Liabilities for the year ending December 31, 2018: USD 205.35 M

BB Biotech AG Total Liabilities is USD 205.35 M for the year ending December 31, 2018. Total liabilities are the total amount of a company's debts and other obligations.

Competitors

Blackstone Inc.

USD 159.80

-3.56 -2.18%

Apollo Global Management, Inc.

USD 145.72

APO

-2.81 -1.89%

MSCI Inc.

USD 563.13

MSCI

-7.53 -1.32%

The Carlyle Group Inc.

USD 57.64

-1.33 -2.25%

Legal & General Group Plc

USD 3.39

LGEN.L

-0.03 -1.01%

Investment AB Latour (publ)

USD 25.68

LATO-B.ST

-0.09 -0.35%

Ares Capital Corporation

USD 22.75

ARCC

-0.11 -0.48%

Washington H. Soul Pattinson and Company Limited

USD 26.80

SOL.AX

-0.01 -0.04%

Kingdom Holding Company

USD 2.24

4280.SR

+0.02 0.84%

Intermediate Capital Group plc

USD 26.45

ICG.L

-0.25 -0.95%

Zegona Communications plc

USD 9.90

ZEG.L

-0.17 -1.68%

StepStone Group Inc.

USD 58.85

STEP

-1.12 -1.87%

Vontobel Holding AG

USD 85.07

VONN.SW

-0.52 -0.61%

Bridgepoint Group plc

USD 4.48

BPT.L

-0.03 -0.58%

Quilter plc

USD 2.22

QLT.L

+0.01 0.44%

Caledonia Investments plc

USD 48.23

CLDN.L

-0.71 -1.44%

HarbourVest Global Private Equity Ltd.

USD 33.92

HVPE.L

+0.15 0.45%

Grosvenor Capital Management, L.P.

USD 11.64

GCMG

-0.15 -1.27%

Ninety One Group

USD 2.46

NY1.JO

+0.02 0.75%

Pantheon International PLC

USD 4.26

PIN.L

-0.00 -0.03%

Key Data

Date	Total Liabilities	Shareholders' Equity	Cash and Short-Term Investments	Receivables